BD will begin rolling out its latest technology for sorting and characterizing the myriad cells that make up the human body, with a speed and clarity that the company says could help identify new ...
FRANKLIN LAKES, N.J., June 3, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it will introduce new cell sorting ...
Spectral flow cytometry collects the full emission spectrum of a fluorochrome, enabling multicolor panels with more parameters than conventional flow cytometry. As scientists discover the subtle ...
New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a ...
FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the global commercial launch of the world's ...
FRANKLIN LAKES, N.J., May 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the worldwide commercial launch of a ...
Spectral flow cytometry is an established technology that offers the ability to extract autofluorescence, gives researchers more flexibility when it comes to fluorochrome selection, and facilitates ...
After five decades of use, flow cytometry is entrenched in biomedical science. Besides enabling the quick processing of cells in suspension, flow cytometry provides quantitative results across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback